Functional and oncological outcomes of salvage external beam radiotherapy following robot-assisted radical prostatectomy in a Canadian cohort

Authors

  • Khaled Ajib Universite de Montreal
  • Marc Zanaty Universite de Montreal
  • Mansour Alnazari Universite de Montreal
  • Emad Rajih
  • Pierre-Alain Hueber
  • Mila Mansour
  • Roger Valdivieso
  • Cristina Negrean
  • Pierre I. Karakiewicz
  • Daniel Taussky
  • Guila Delouya
  • Assaad El-Hakim Universite de Montreal
  • Kevin C. Zorn Universite de Montreal

DOI:

https://doi.org/10.5489/cuaj.4641

Abstract

Introduction: We sought to determine the impact of salvage radiotherapy (SRT) on oncological and functional outcomes of patients with prostate cancer after biochemical recurrence (BCR) following robot-assisted radical prostatectomy (RARP).

Methods: Data of 70 patients with prostate cancer treated with SRT after developing BCR were retrospectively analyzed from a prospectively collected RARP database of 740 men. Oncological (prostate- specific antigen [PSA]) and functional (pads/day, International Prostate Symptom Score [IPSS], and Sexual Health Inventory for Men [SHIM]) outcomes were reported at six, 12, and 24 months after RT and adjusted for pre-SRT status.

Results: Men who underwent SRT had a mean age, PSA, and time from radical prostatectomy (RP) to RT of 61.8 years (60.1‒63.6), 0.5 ng/ml (0.2‒0.8), and 458 days (307‒747), respectively. Freedom from biochemical failure (FFBF) post-SRT, defined as a PSA nadir <0.2 ng/mL, was observed in 89%, 93%, and 81%, at six, 12, and 24 months, respectively. Undetectable PSA was observed in 14%, 35%, and 40% at the same time points, respectively. There was no significant difference in urinary continence post-SRT (p=0.56). Rate of strict continence (0 pads/day) was 71% at 24 months compared to 78% pre-SRT. Mean IPSS at six, 12, and 24 months was 3.4, 3.6, and 3.6, respectively compared to pre-RT score of 3.3 (p=0.61). The mean SHIM score pre-SRT was comparable at all time points following treatment (p=0.86).

Conclusions: In this unique Canadian experience, it appears that early SRT is highly effective for the treatment of BCR following RARP with little impact on urinary continence and potency outcomes.

Downloads

Download data is not yet available.

Published

2017-12-01

How to Cite

Ajib, K., Zanaty, M., Alnazari, M., Rajih, E., Hueber, P.-A., Mansour, M., Valdivieso, R., Negrean, C., Karakiewicz, P. I., Taussky, D., Delouya, G., El-Hakim, A., & Zorn, K. C. (2017). Functional and oncological outcomes of salvage external beam radiotherapy following robot-assisted radical prostatectomy in a Canadian cohort. Canadian Urological Association Journal, 12(2), 45–9. https://doi.org/10.5489/cuaj.4641

Issue

Section

Original Research